When Reese and colleagues used IHC and FISH analyses to evaluate HER2 expression and gene amplification in 39 androgen-independent PC samples, they found that 36% expressed HER2 but only 5% had either moderate expression (2+) or high-level expression (3+). Here, ERBB2 is linked to pachyonychia congenita.